A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.
Kulisevsky J, Martínez-Horta S, Campolongo A, Pascual-Sedano B, Marín-Lahoz J, Bejr-Kasem H, Labandeira-Garcia JL, Lanciego JL, Puig-Davi A, Horta-Barba A, Pagonabarraga J, Rodríguez-Antigüedad J.
Kulisevsky J, et al.
Parkinsonism Relat Disord. 2023 May;110:105367. doi: 10.1016/j.parkreldis.2023.105367. Epub 2023 Mar 21.
Parkinsonism Relat Disord. 2023.
PMID: 36963339
Clinical Trial.
No abstract available.